The FDA amended the emergency use authorizations (EUAs) for both the Pfizer BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine to allow for an additional dose in certain immunocompromised people.
Related Posts
EmblemHealth: LabCorp is now part of EmblemHealth’s network
In January, Labcorp and its affiliated specialty labs joined EmblemHealth’s laboratory network for EmblemHealth Plan, Inc. (formerly GHI) members.To set…
New Jersey Medical Society Triumphs with Virtual Credit Card Bill
In a monumental move, the Medical Society of New Jersey (MSNJ) has recently achieved a significant victory in its ongoing…
Medicaid of NY: The Pharmacy Carve-Out Has Been Delayed by Two Years
Delay Transition of Medicaid Pharmacy Benefit: The FY 2021 Enacted Budget transitioned the Medicaid pharmacy benefit from Managed Care to Fee…